http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-P20200196-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-72
filingDate 2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4c71da3454b695e541bbb0916d09b3b
publicationDate 2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JO-P20200196-A1
titleOfInvention Use 5-fluoro-4- (4-fluoro-2-methoxyphenyl) - N- {4 - [(S-methyl sulfone imidoyl) methyl] pyridine-2-yl} pyridine-2-amine to treat widespread B-cell lymphoma
abstract Abstract The present invention relates to the use of 5- fluoro-4- (4-fluoro-2-methoxyphenyl) - N- {4 - [(S-methyl sulfurone imidoyl) methyl) pyridine-2-yl} pyridine-2-amine (the compound A), namely (+) 5- fluoro-4- (4-fluoro-2-methoxyphenyl) - N- {4 - ((S-methyl sulfurate imidoyl) methyl) pyridine-2-yl} pyridine-2-amine (Compound A), for the treatment of diffuse large B-cell lymphoma, especially for diffuse macrophage B-cell lymphoma and in particular for diffuse large B-cell lymphoma characterized by amplification or translocation of the MYC gene and / or the BCL2 gene and / or the overexpression of MYC and / or BCL2. .
priorityDate 2018-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414931982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74767009

Total number of triples: 17.